Recombinant Human Prourokinase is developed through recombinant DNA technology, a single chain structure urokinase that activates plasminogen on the fibrin and induces fibrin-selective clot lysis.

Use this medication precisely as recommended by your physician. Follow the prescription of your doctor carefully. 

The medication dose your physician has given is based on your condition, other medications or food supplements you may take, and your reaction to treatment. To diminish your risks for adverse effects, don’t increase your dosage, take it regularly, or take it as instructed by your physician. Adverse events may still happen even at usual prescription dosages. 

If your physician requests you to use this drug consistently, use it regularly to get the most benefits from it. To make you remember it better, take it at a fixed time every day. 

Your doctor may need to modify your dosages to ease your symptoms or if you develop adverse reactions. 

If you have any inquiries with regards to information, ask your physician or pharmacist.

Recombinant Human Prourokinase is used in the following conditions:

  • Acute MI

This medicine may be recommended for different uses. Approach your physician or pharmacist for more information.  

Do not use Recombinant Human Prourokinase in people with the following conditions:

  • Hypersensitivity
  • Conditions manifested by increased bleeding
  • Active bleeding
  • Extensive trauma up to 4 weeks
  • Cardiogenic shock
  • Puncture of uncompressed vessels
  • Diabetic hemorrhagic retinopathy
  • Previous hemorrhagic stroke
  • High blood pressure
  • Suspicion of aortic dissection
  • Septic endocarditis
  • Hepatic impairment
  • Pregnancy
  • Lactation

Recombinant Human Prourokinase may have the following side effects:

Keep in mind that your physician has recommended this drug since he or she has known that the advantage to you is more noteworthy than the risk of adverse reactions. Many individuals utilizing this medicine don’t have serious side effects.  

A serious allergy to this medication is uncommon. In any case, seek emergency medical help if you see any manifestations of a serious allergic response, including a rash, tingling or swelling particularly of the face or tongue or throat, dizziness or difficulty in breathing. 

This is not a complete list of side effects. If you see other effects not recorded above, contact your physician or pharmacist.

Take extra caution in patients with the following medical conditions:

  • Renal impairment

Prior to taking this medicine, tell your physician or pharmacist if you are allergic to it, or if you have some other hypersensitivities. This drug may contain inert ingredients which can cause unfavorable side effects or different issues. Talk with your pharmacist for more information.


Recombinant Human Prourokinase may interact with the following medicines:

  • Antiplatelet agents
  • Indirect coagulants
  • Heparin

This article does not contain all possible drug interactions because it may change how your medications work or increase your risk for serious side effects.  Keep a list of all the products you use and consult it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor’s approval.

Inform your physician about the drugs you take including over-the-counter medications, prescribed drugs, supplements and vitamins. 

This is not a complete list of drug interactions. Approach your physician or pharmacist for more details. 

The effects of certain medications can change if you consume different medications or herbal products simultaneously. This can build your risk for side effects or may cause your drugs not to work effectively. These interactions are conceivable, yet don’t generally happen. Your physician or pharmacist can prevent or oversee interactions by changing how you utilize your prescriptions or by close checking. 

While utilizing this drug, don’t start, stop, or change the dose of other medicines you are using without your physician’s advice.

Symptoms of overdose may include the following:

  • Haemorrhagic complications

Seek medical help immediately. 

Available Brand:

  • Abbokinase

Related Articles


The 9-valent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]


The quadrivalent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]


HiB Conjugate Vaccine (Meningococcal Protein Conjugate) induces the development of anticapsular antibodies, which protect against infection with Haemophilus influenzae type [...]